Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
14.09
-0.05 (-0.35%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Iovance Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $20 | Buy | Maintains | $20 | +41.94% | Oct 23, 2026 |
| Barclays | Barclays | Buy Maintains $15 → $18 | Buy | Maintains | $15 → $18 | +27.75% | Oct 13, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $6 → $11 | Hold | Maintains | $6 → $11 | -21.93% | Oct 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $14 → $18 | Buy | Reiterates | $14 → $18 | +27.75% | Sep 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +41.94% | Sep 29, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $10 → $16 | Buy | Maintains | $10 → $16 | +13.56% | Sep 29, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $15 | Buy | Initiates | $15 | +6.46% | Sep 24, 2026 |
| UBS | UBS | Hold Reiterates $4 → $7 | Hold | Reiterates | $4 → $7 | -50.32% | Aug 20, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.